Volume 2, Issue 2, Page 2 (February 2007)
5 of 70
PREVIEW
FULL TEXT
FULL-TEXT PDF (94 KB)
CITATION ALERT
CITED BY
RELATED ARTICLES
EXPORT CITATION
EMAIL TO A COLLEAGUE
RIGHTS/PERMISSIONS
NEED REPRINTS?
BOOKMARK ARTICLE
A dietary supplement marketed as Liviro3 is being recalled because Food and Drug Administration tests have discovered it contains tadalafil, the phosphodiesterase type 5 inhibitor marketed as Cialis to treat erectile dysfunction.
PII: S1558-0164(07)70053-6
doi:10.1016/S1558-0164(07)70053-6
© 2007 Elsevier Inc. All rights reserved.
Copyright © 2012 Elsevier Inc. All rights reserved. | Privacy Policy | Terms & Conditions | Feedback | About Us | Help | Contact Us | The content on this site is intended for health professionals.
PREVIEW